(Micro)tubular bells chime for Veru with phase II pill against COVID-19 demon Feb. 8, 2021 By Randy Osborne No Comments CEO Mitchell Steiner said Veru Inc. at first downplayed the prospects of oncology candidate VERU-111 in COVID-19 treatment but now, with positive phase II data in hand, the company has a moral obligation to push onward to late-stage research.Read More